Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DSXS 1538b in scalp psoriasis
NCT02933502Phase 2Completed
- Start
- Jul 2016
- Primary completion
- Sep 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of desoximetasone in psoriasis. Primary endpoint: Number of Participants With HPA Axis Suppression at day 28. Started Jul 2016; status: completed.
02
Drugs
desoximetasone
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT02933502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02933502.